Search research articles
Contact Us
Filters
Showing results (271-280 of 284) with videos related to
Page
of 29
Sort By:
Nature Communications
|
October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Dominiek Smeets, Ian S Miller, Darran P O'Connor, et al.
The British Journal of Surgery
|
July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study
Georgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Science Translational Medicine
|
August 14, 2024
Acyl-CoA binding protein for the experimental treatment of anorexia
Hui Chen, Stéphanie Moriceau, Adrien Joseph, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 16, 2025
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study
Davide Ciardiello, Luca Boscolo Bielo, Stefania Napolitano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2019
A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study
Fotios Loupakis, Rossana Intini, Chiara Cremolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2025
The Impact of Concordance Between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the Rome Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, et al.
Nature Medicine
|
June 3, 2025
Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer
Gianmarco Piccinno, Kelsey N Thompson, Paolo Manghi, et al.
Nature Medicine
|
September 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni, et al.
Nature Medicine
|
December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Jayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
Nature Communications
|
April 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer
Joan Choo, Joseph J Zhao, Mai Chan Lau, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 284) with videos related to
Sort By:
Page
of 29
Nature Communications
|
October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Dominiek Smeets, Ian S Miller, Darran P O'Connor, et al.
The British Journal of Surgery
|
July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study
Georgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Science Translational Medicine
|
August 14, 2024
Acyl-CoA binding protein for the experimental treatment of anorexia
Hui Chen, Stéphanie Moriceau, Adrien Joseph, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 16, 2025
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study
Davide Ciardiello, Luca Boscolo Bielo, Stefania Napolitano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2019
A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study
Fotios Loupakis, Rossana Intini, Chiara Cremolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2025
The Impact of Concordance Between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the Rome Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, et al.
Nature Medicine
|
June 3, 2025
Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer
Gianmarco Piccinno, Kelsey N Thompson, Paolo Manghi, et al.
Nature Medicine
|
September 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni, et al.
Nature Medicine
|
December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Jayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
Nature Communications
|
April 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer
Joan Choo, Joseph J Zhao, Mai Chan Lau, et al.
Page
of 29